GENERAL ASPECTS AND CLINICAL MANIFESTATIONS IN YOUNG PATIENTS WITH PRIMARY MYELOFIBROSIS.

Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054-1061.

Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood. 2009;114:937-951.

Corcimaru I., Hematologie 2007; 190

Primary myelofibrosis: own experience and news from diagnostic and treatment K.M. Abdulkadyrov, V.A. Shuvaev, I.S. Martynkevich Russian Research Institute of Hematology and Transfusiology, Federal Medical and Biological Agency; 16, 2 nd Sovetskaya St., St. Petersburg, 191024, Russia, p 26.

Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Ayalew Tefferi 1